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There is no dietary strategy that has yet been specifically advocated for hemophilia. 
Therefore, we sought to assess the effect of the Dietary Approaches to Stop Hypertension 
(DASH) diet in adolescents with hemophilia. In this parallel trial, 40 male adolescents with 
hemophilia were dichotomized into the DASH group or control group for 10 weeks. The 
serum high sensitivity C-reactive protein (hs-CRP), interleukin 6 (IL-6), complete blood 
count (CBC), serum glutamic oxaloacetic transaminase (SGOT), serum glutamic pyruvic 
transaminase (SGPT), partial thromboplastin time (PTT), waist circumference (WC), 
percentage of body fat, fat-free mass (FFM), and liver steatosis were measured at the 
beginning and end of the study. Serum vitamin C was measured as a biomarker of 
compliance with the DASH diet. The DASH diet was designed to include high amounts of 
whole grains, fruits, vegetables, and low-fat dairy products, as well as low amounts of 
saturated fats, cholesterol, refined grains, sweets and red meat. Serum vitamin C in the DASH 
group was significantly increased compared to the control (P=0.001). There was a significant 
reduction in WC (P=0.005), fat mass (P=0.006), hepatic fibrosis (P=0.02), and PTT 
(P=0.008) in the DASH group, compared with the control. However, there were no 
significant differences regarding other selected outcomes between groups. Patients in the 
DASH group had significantly greater increase in the levels of red blood cell, hemoglobin, 
and hematocrit, as compared to control. Adherence to the DASH diet in children with 
hemophilia yielded significant beneficial effects on body composition, complete blood count, 
inflammation, and liver function. 
Keywords: Hemophilia, Dietary approach to stop hypertension, body composition, complete 
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Hemophilia is a hereditary hemorrhagic disorder caused by a deficient or defective clotting 
factor VIII (type A hemophilia) or clotting factor IX (type B hemophilia) (1). The inheritance 
pattern of this disorder is X-linked recessive, therefore, hemophilia is exclusively transmitted 
through female carriers and affects only males (2). Recent evidence has shown that more than 
1,125,000 men suffer from hemophilia around the world (3). The World Federation of 
Hemophilia has announced that Iran is among the top ten countries with the highest 
prevalence of hemophilia, globally (4). 
When a male patient manifests unusual hemorrhagic episodes, with an elevated partial 
thromboplastin time (PTT) but normal prothrombin time and platelet count, the diagnosis of 
hemophilia is suspected (2). The extent of coagulation factor VIII or IX deficiency 
determines the probability and severity of internal and external bleeding (1). Depending on 
age, the predominant sites of hemorrhage are also varied; for instance, hemophilic newborns 
and toddlers are usually affected by head bleeding, while hemophilic adolescents typically 
experience intra‐articular bleeding, known as hemarthrosis (5). Therefore, management of the 
disease becomes increasingly important in these subjects. 
Prolonged hemorrhage, as evidenced by an elevated PTT, is a major concern in hemophilic 
patients (2). Due to recurrent bleeding and hemolysis, mild anemia is also a common 
complication in subjects with hemophilia (6). Moreover, recent evidence has suggested that 
hemophilic individuals have chronic low-grade inflammation, originating from increased 
levels of lipopolysaccharide in their blood circulation (7). Furthermore, hemarthrosis and 
subsequent synovitis and arthropathy make hemophilia sufferers less physically active in 
comparison to others (8). Therefore, overweight, obesity, and non-alcoholic fatty liver 
disease are prevalent comorbidities in this population (9). Unfortunately, no dietary approach 
has yet been designed or advocated to specifically manage the aforementioned problems in 
patients with hemophilia. 
The Dietary Approaches to Stop Hypertension (DASH) diet is a well-known eating pattern, 
with multiple, documented, beneficial effects on weight management, body composition, 
liver function, inflammatory biomarkers, and some other aspects of human health (10-12). 
Adherence to this multifunctional diet creates a unique balance between the consumption of 
plant-based foods, including whole grains, fruits, vegetables, legumes, and nuts, and animal-
based foods, including poultry, fish, and dairy products. In addition, it limits the intake of 
salt, red meat, fatty foods, and sugar-sweetened beverages and foods (13). To the best of our 
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hemophilic children and adolescents. Therefore, we sought to conduct a randomized 
controlled trial to assess the effect of the DASH diet on hematological parameters, 
inflammatory biomarkers, anthropometric indices, body composition, and liver function in 
adolescents with hemophilia. 
Method: 
Participants: 
The present parallel randomized clinical trial was conducted from March to June 2020. A 
total of 40 adolescents with hemophilia were recruited from Omid Hospital, Isfahan, Iran. 
Volunteers were eligible if they 1) were male, 2) were aged between 10 to 18 years old, 3) 
had clotting factor (VII, VIII and IX) deficiency, 4) had not used antioxidant supplements 
within the preceding 3 months, and 5) were not on a specific diet. Also, incidence of a new 
chronic disease during the study has been considered as a premature withdrawal. The sample 






 where α=0.05 (type one error) and β=20% 
(type two error). Body mass index (BMI) was considered as the main variable. A previous 
study showed that the standard deviation of BMI in hemophilic patients was 2.08 kg/m2 (14), 
and the minimal detectable difference of BMI was 1.34 kg/m
2
. Accordingly, 40 hemophilia 
adolescents were recruited for the current clinical trial. An introductory session was set up to 
clarify plans and details regarding the study. Written consent was completed by parents and 
adolescents, and the study was ethically approved by The Research Council and Ethical 
Committee of Isfahan University of Medical Sciences, Isfahan, Iran, and Food Security 
Research Center, Isfahan University of Medical Sciences, Isfahan, Iran (Code: 
IR.MUI.RESEARCH.REC.1399.098). This randomized clinical trial was registered at 
IRCT.ir (IRCT20130903014551N6). 
Study Procedure and Dietary Intervention: 
In this current study, participants were randomly dichotomized into the DASH group (n=20) 
or control group (n=20) for 10 weeks. Each subject received a code and randomization was 
run using select random number in SPSS 20. As is was a dietary intervention, patients and 
their parents could not be blinded. In DASH group, energy requirements of each participant 
were calculated individually based on the Harris–Benedict equation (15). The DASH diet was 
determined based on the previously modified DASH diet for adolescents (16), where the 
macronutrient composition was as follows: 50-55% of total energy from carbohydrates, 16-
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designed to include high amounts of whole grains, fruits, vegetables, and low-fat dairy 
products, as well as low amounts of saturated fats, cholesterol, refined grains, legumes, nuts, 
sweets and red meat. A sample of one-day menu is demonstrated in Table 1. Also, the 
consumption of red meat and sodium was limited. In this way, limiting red meat was applied 
by reducing the amount of red meat per serving in the diet and replacing red meat with white 
meat and poultry. It is recommended to consume a maximum of 180 g of meat per day with 
emphasis on the consumption of fish and white meat. Following recommendations were used 
to limit sodium intake: 1) avoid using of table salt, 2) cooking low-salt food, 3) limit using 
sodium-rich foods such as pickles and processed foods, and 4) use of low-salt cheese and 
breads. A maximum sodium intake of 2300 mg per day was allowed. All adolescents and 
their parents attended the meetings to learn daily food menus. Adolescents in the control 
group received nutritional recommendations based on healthy eating behaviors, including 
chewing food completely, using low-volume frequent meals, using healthy snacks, drinking 
adequate water, avoiding deep frying, limiting added fat and sugar. Serum vitamin C was 
defined as a biochemical indicator of compliance with DASH diet (17). Accordingly, 
compliance with the DASH diet was assessed by measuring serum vitamin C at baseline and 
after 10 weeks of intervention. Serum vitamin C was measured using biochemical 
colorimetric analysis. All patients and their parents participated in meetings programmed at 







 week of the study. So, three, one-day food records (two weekdays and 
one weekend day) were completed by each participant, and a researcher investigated the 
completeness of food diaries with parents. All collected food records were analyzed using the 
USDA database. 
Measurement of Biochemical Variables: 
Blood samples were drawn after 12 h of fasting, in the early morning, from the antecubital 
vein, and all of the related concentrations were prepared on the day of blood sampling. 
Samples were centrifuged at 3000×g for 10 min to separate the serum. High sensitivity C-
reactive protein (hs-CRP) was measured using the Inm.turbid method by Audit kit (Delta 
treatment, Ireland-Iran), and interleukin 6 (IL-6) was measured by using the commercially 
available enzyme-linked immunosorbent assay kits (Siemens, Germany) by CLIA. Complete 
blood counts (CBC) were conducted using an automated procedure (Mindray apparatus). 
Serum glutamic oxaloacetic transaminase (SGOT) and serum glutamic pyruvic transaminase 








bridge.org/core . IP address: 194.66.32.10 , on 21 D
ec 2021 at 14:44:15 , subject to the Cam
bridge Core term







Partial thromboplastin time (PTT) tests were performed using the turbidometry method by IL 
kits (Instrument Lab, Germany). In the present study, serum vitamin C was measured using 
vials previously treated with meta-phosphoric acid based on a biochemical colorimetric 
analysis. 
Measurement of Anthropometric Variables and Body Composition: 
Weight was measured to the nearest 100 g, with participants minimally clothed and unshod, 
whilst height was measured using a standard stadiometer according to standard protocols. 
BMI was calculated as weight in kilograms divided by the square of height in meters. Waist 
circumference (WC) was measured at the narrowest level, over light clothing, using a non-
stretchable tape measure, without any pressure to the body surface. Weight, height and BMI 
percentiles were calculated based on Centers for Disease Control and Prevention (CDC) 
growth charts for children and adolescents, aged 2 to19 years (18). Body fat and fat free mass 
(FFM) were measured using bioelectrical impedance analysis (BIA) (Bodyvis A_1c, China), 
which is highly correlated with dual X-ray absorptiometry (r=0.88)  (19). All measurements 
were conducted at baseline and at the end of the trial. 
Measurement of Fibrosis and Steatosis 
Liver fat was measured using FibroScan, and accepted as the reference standard. All biopsy 
specimens were investigated by a circulatory expert who specialized in liver diseases. The 
probe transducer tip was located on the skin between the ribs and the level of the right lobe of 
the liver. The =depth was between 25 and 65 mm under the skin exterior (20). Stages were 
recognized according to the NASH Clinical Research Network scoring system (21). 
Statistical Analysis: 
The analyses were performed on the basis of an intention-to-treat (ITT) approach. Missing 
values were treated according to linear regression method. To evaluate the distribution of 
variables, we used the Kolmogrov-Smirnov test, which demonstrated that body fat, SGPT, 
and CRP, were not normally distributed. Therefore, log transformation was applied. 
Quantitative variables were analyzed between two groups utilizing an Independent Student t-
test, whilst an analysis of covariance (ANCOVA) was conducted to set confounding 
variables, especially baseline values. Data were presented as means and standard deviations, 
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Among the 40 subjects with hemophilia who enrolled in the study, three patients in the 
DASH diet group (due to medical conditions and personal reasons) and four patients in the 
control group (due to medical conditions and low adherence to intervention) were excluded 
from follow up data collection (Figure 1). During the study process, two subjects had low 
adherence and they did not want to continue participation. Therefore, they excluded 
according to their tendency and researchers had no role in excluding these subjects. 
Nevertheless, baseline measurements were performed for these patients and we run ITT 
analysis according to the baseline measurements.  
We excluded two subjects from control group because they stated that they did not start being 
on the prescribed diet. Therefore, we did not follow them because they had no compliance 
with prescribed diet. At the end of the study, we included baseline data of the all subjects 
randomly assigned to the DASH or control groups using an intention to treat method 
The analyses were performed according to ITT approach; therefore, all 40 participants were 
enrolled in the final analyses. There were no side effects following the DASH diet among the 
participants. 
Table 2 indicates baseline characteristics of study participants in each group. There were no 
significant differences between the groups in terms of age, BMI percentile, and WC. 
However, at baseline, individuals in the DASH diet group had higher weight and height 
percentiles, compared to those in control group. 
Dietary intake of the study participants as a sum of the three one-day food records are 
presented in Table 3. Based on food diaries, the mean intakes of energy, carbohydrate, 
protein, fat, vitamin A, vitamin E, vitamin C, vitamin K, vitamin B1, vitamin B2, selenium, 
zinc, iron and dietary fiber during the trial were not significantly different between groups. 
As expected, dietary intakes of sodium were significantly lower (1172.35 vs. 1580.94 
mg/day, p = 0.002), while calcium intakes were higher (754.26 vs. 545.28 mg/day, p = 
0.017), in the DASH, vs. control group. Individuals in the DASH group had higher intakes of 
potassium (1987.52 vs. 1624.36 mg/day, p = 0.040) as compared with those in the control 
group. 
Figure 2 presents serum vitamin C levels at baseline and at the end of trial in each group. At 
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group (0.28 mg/dL) and control group (0.10 mg/dL) compared to baseline values. Between 
group comparison indicated a significant increase in serum vitamin C levels in the DASH 
group compared to control group (p=0.001), suggesting a relatively good compliance of the 
participants to the DASH diet. 
Table 4 details the effect of the DASH diet on anthropometric indices, inflammation, and 
liver histology and enzymes. Within group comparison showed a significant reduction in WC 
(-2.25 cm), FAT (-0.52 kg), and PTT (-8.48), and a significant rise in FFM (1.25 kg), in the 
DASH diet group. Also, a significant increase was seen regarding FAT (0.88 kg), CRP (2.22 
mg/L), and hepatic fibrosis (0.15 kPa) in the control group. Compared with the control group, 
adherence to the DASH diet led to significant reductions in WC (P= 0.005), FAT (P= 0.006), 
hepatic fibrosis (P= 0.02,) and PTT (P= 0.008). There were no significant differences 
regarding other selected outcomes between groups. To attenuate the difference in baseline 
values, the effect of baseline measurements were adjusted. 
The effects of DASH diet on CBC profile are presented in Table 5. Whithin group analysis 
showed that WBC, RBC, HGB, HCT, and MCH were significantly increased after using 
DASH diet. Patients in the DASH group had significantly greater increase in the levels of 
RBC (P= 0.02), HGB (P= 0.005) and HCT (P= 0.006), compared to control group. To 
attenuate the difference in baseline values, the effect of baseline measurements were adjusted. 
Discussion 
In the current study, adherence to the DASH diet, for 10 weeks, among hemophilic 
adolescents resulted in a significant reduction in WC, fat mass, fibrosis, and PTT, in 
comparison to the control group. In addition, RBC, HGB, and HCT significantly increased, 
whilst steatosis and CRP levels were marginally reduced, in response to following the DASH 
diet, compared with the control group. However, changes in weight, BMI, FFM, IL-6, SGOT, 
SGPT, MCV, MCH, and MCHC were not significantly different between the two groups. To 
the best of our knowledge, this is the first study investigating the effects of the DASH diet on 
body composition, complete blood count, inflammatory markers, and liver function in 
hemophilic adolescents. It has previously been demonstrated that overweight and obesity are 
major issues when concomitant to hemophilia,  and are associated with several metabolic 
abnormalities (9). With regard to the difficulties of these patients to be physically active (22, 
23), following a healthy diet and decreasing calorie intake are suggested as key factors in the 
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currently, no dietary recommendation has been specifically advocated for these patients. 
Therefore, our findings, which indicated the beneficial effects of the DASH diet on several 
health aspects of hemophilia, might be useful in clinical settings to prevent and treat health 
complications of these patients.  
The results of our study showed that serum vitamin C level significantly increased following 
the DASH diet, compared with the control diet. In addition, intake of soluble fiber and 
calcium were significantly higher, and sodium intake was notably lower, in the DASH group 
vs. control group. Currently, serum vitamin C level and dietary records represent the best 
tools to assess the compliance of study participants to the DASH diet (17). Concordant with 
our results, in a previous study conducted on children with metabolic syndrome, serum 
vitamin C significantly increased following the DASH diet, compared with the control group 
(17). Indeed, it has been suggested that consumption of vitamin C may be associated with 
lower blood pressure, by enhancing nitric oxide synthase activity (24, 25). Therefore, one of 
the possible explanations for the anti-hypertension effects of the DASH diet might be due to 
the high fruits and vegetable content of this diet. Indeed, the focus of the DASH diet is on 
vegetables, fruits, and low-fat dairy foods (26), thus, a significant increase in the soluble fiber 
and calcium intake is predictable among intervention participants, as compared to controls.  
In the present study, WC and fat mass were significantly decreased in response to adherence 
to the DASH diet in comparison with the control diet. However, the differences between 
weight, BMI, and FFM did not significantly differ between groups. It has previously 
suggested that overweight and obesity, which are highly prevalent among hemophilia 
patients, are associated with annual joint bleeding rate and influence the joint health of these 
patients (27-29). It has also been widely demonstrated that overweight and obesity contribute 
to the reduction in motion of joints, acceleration of loss of joint mobility, and increasing 
chronic pain (29). Given that obesity in hemophilia patients is associated with an increasing 
prevalence of anxiety and depression and several other negative health consequences (29), 
prevention and treatment of obesity is necessary in these patients. However, generally, weight 
reduction during childhood is not recommended and the aim of the diet therapy should be the 
maintenance of weight among children and adolescents. Therefore, our results, which 
indicate that adherence to the DASH diet, for ten weeks, can maintain BMI and FFM, in 
addition to facilitating reductions in WC and fat mass, in adolescents with hemophilia, 
suggest that the DASH diet is a practical and safe dietary approach to help prevent obesity 
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results of a systematic review and meta-analysis showed that, in comparison to the control 
diet, adherence to the DASH diet elicited a significant reduction in weight, BMI, and WC 
among adults (30). Moreover, the results of a cohort study showed that, after 3-years follow-
up, the DASH diet had an inverse association with central and general obesity among 
adolescents (31). In another previous study, it was reported that, after 6 weeks adherence to 
the DASH diet, weight, BMI, and WC did not significantly change compared with usual 
dietary habits among children with metabolic syndrome (17). In Saneei et al, WC was 
significantly reduced in the DASH diet group compared with baseline, however, although the 
mean change of WC was higher in the DASH diet compared with control diet, it was not 
statistically significant (17). Thus, discordance in findings of some previous work and our 
study, in terms of WC, might be attributable to the difference in compliance and longer 
treatment time of our study (10 weeks vs. 6 weeks). Overall, the favorable effects of the 
DASH diet on WC and body composition in our sample might be due to the fact that the 
DASH diet is rich in fruits and vegetables, legumes, and low fat dairy products, as well as 
healthy vegetable oils, which provide a low-calorie dietary pattern and simultaneously 
provides suitable amounts of nutrients for the growth and development of children and 
adolescents. 
In our study, fibrosis and steatosis were markedly decreased in the DASH diet group 
compared with the controls. Although Nonalcoholic fatty liver disease (NAFLD) is often 
associated with adulthood, recent studies have shown that the risk of developing NAFLD in 
adolescents has doubled in the past 20 years (32). Recent studies have presented NAFLD as 
one of the two most important complications of obesity in children and adolescents(33). Also, 
it should be noted that children with hemophilia have limited physical activity due to the risk 
of bleeding, which increases the risk of NAFLD. In a previous randomized controlled trial 
study, in comparison to controls, following the DASH diet for 8 weeks among adult 
Nonalcoholic Fatty Liver Disease (NAFLD) patients resulted in improvements in several 
metabolic factors, such as weight, BMI, triglycerides, markers of insulin metabolism, 
inflammatory, and stress oxidative markers of these patients (11). Similarly, observational 
studies have reported that consumption of the DASH diet has an inverse correlation with risk 
of NAFLD (34, 35). As mentioned above, hemophilia patients have several hindrances to 
being physically active and they are at high risk for obesity and related metabolic diseases. 
One the most important undesirable outcomes of being physically inactive and gaining 
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is insulin resistance, which has a bilateral association with fatty liver (36, 37). The beneficial 
effects of the DASH diet on the metabolic status of patients with hemophilia might be 
explained by the low amounts of simple sugar and higher fibre, magnesium, and calcium of 
this dietary pattern, which may reduce markers of insulin metabolism, triglycerides, and very 
low density lipoprotein (VLDL)‐cholesterol levels (38). It has recently been shown that 
consumption of sugar-sweetened soda has a direct correlation with increased risk of NAFLD, 
since they possess high amounts of fructose and calories which both have a substantial role in 
the etiology of fatty liver (39, 40). Animal studies have shown that high calcium and 
magnesium diets, as exists in the DASH eating pattern, have a salient role in stimulating 
microsomal triglyceride transfer protein (MTP) in the liver (41), suppression of endothelial 
injury, reduction in the peroxidation of lipids, and enhancing the antioxidant capacity in both 
serum and tissues (42).  
The findings of the present study demonstrated that consumption of the DASH diet yielded, 
albeit marginal, significantly reduced serum CRP levels compared with the control group. In 
accordance with our results, it has been shown that following the DASH diet significantly 
reduced hs-CRP among adolescents with metabolic syndrome (17), adult NAFLD patients 
(11), and Polycystic ovary syndrome (43) patients compared with control groups. 
However, adhering to the DASH diet for 4 weeks did not lead to reductions in hs-CRP in 
women with gestational diabetes, while it significantly increased plasma total antioxidant 
capacity (TAC) and total glutathione (GSH) (44). Several potential mechanisms have been 
posited regarding the anti-inflammatory effects of DASH diet,  including high amounts of 
anti-oxidants, such as vitamin C, and high amounts of calcium, magnesium, and fibre present 
within this diet (45-47). It has previously been shown that magnesium inhibits nuclear factor 
kappa-light-chain-enhancer of activated B cells (NF-κB), and has a role in the down-
regulation of the inflammatory response (48, 49). 
One the most valuable findings of our study is that PTT significantly decreased after 
consumption of the DASH diet compared with the control diet. A prolongation in the PTT is 
occurrent in patients with hemophilia, even in some cases with severe hemophilia the PTT is 
2 to 3 times longer than the normal range (50). However, to our knowledge, there is no study 
that has assessed the relationship between healthy dietary patterns and PTT, thus, more 
preclinical and clinical trials are needed to clarify our results and its underlying mechanisms. 
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increases vitamin K intake (51). In addition, DASH diet is a rich source of dietary fiber which 
can lead to more vitamin K production by altering gut microbiota (52).  These suggested 
mechanisms should be investigated by additional studies. Similarly, our results indicated that 
adherence to the DASH diet significantly increased RBC, HGB, and HCT compared with the 
control group, which might due to the high antioxidant levels of the DASH diet, which are 
necessary in hematopoiesis (53). 
The average age of the subjects in our study was 13-14 years. According to the WHO height- 
for- age percentile (54), the rate of height growth is about 6-7 cm/year (0.11-0.12 cm/week) 
in this age. The duration of the present study was 10 weeks. Therefore, the subjects had a 
maximum height growth of 1.1-1.3 cm. It should be kept in mind that the impaired growth is 
prevalent among children with chronic disease such as hemophilia (55). Therefore, it is 
unlikely that our findings on body composition were affected by the height growth of the 
subjects 
Strengths and limitations 
The strengths of our study included that; we utilized serum levels of vitamin C as a valid 
biomarker of diet compliance, and we applied the ITT approach for the analysis data, which 
permitted all of the study participants who participated in our study into data analysis. 
Evidence determined that the concentration of sodium and potassium in a 24-hour urine 
sample can be considered as a biomarker of compliance with the DASH diet. Although, 
collecting 24-hour urine samples is difficult, especially for children and adolescents. 
Additionally, day to day variation of 24-hour urinary sodium is high, and multiple samplings 
are required to attenuate day to day variation. [41]. Since it was not suitable for adolescents, 
we utilized vitamin C because it does not have these limitations. Moreover, to the authors’ 
knowledge, this is the first study investigating the effects of the DASH diet, as one the most 
well-known healthy dietary patterns, on liver fibrosis and steatosis using a fibroscan, 
inflammatory factors, anthropometry, and body composition, as well as complete blood count 
among haemophilic adolescents. Nevertheless, as a main limitation of our study, blinding was 
not applicable due to the nature of our intervention. Dietary intakes were not assessed before 
the intervention and all the nutritional assessments were performed during the study. Also, 
dietary intake has been investigated during the study using 3 one-day food records. Due to the 
difficulty of obtaining food records from children with specific disease conditions, we could 
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that the compliance with the intervention has been evaluated by biomarkers (serum vitamin 
C), these limitations had no serious unfavorable effect on the validity of the study. 
 
Conclusion 
Our findings showed that the DASH diet, which was primarily designed to control 
cardiovascular risk factors in healthy or unhealthy adults, has several beneficial effects on 
various health aspects of adolescents with hemophilia. Indeed, adherence to the DASH diet 
significantly reduced waist circumference and fat mass, in addition to eliciting beneficial 
effects on CRP, liver fibrosis, and steatosis, as well as RBS, HGB, and HCT, in hemophilic 
adolescents. However, more, well-designed and well-conducted, studies are needed to 
confirm the results of the present study.  
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Table 1. A sample menu of the prescribed diet to the DASH group (6276 kJ (1500 kcal), 
55% from carbohydrate, 17% from protein, 28% from fats) 
Food groups Serving size per day Food item (g/d) 
Grains 6 Whole-Bread (60) 
Vegetables 5 Whole-Cereals (150) 
Fruits 5 Cooked peas (34) 
Dairy 2 Cooked green beans (42) 
Meat 2.5 Cabbage (93) 
Nuts/Seeds 1 Tomato (60) 
Fats/Oils 6 Green pepper (108) 




Low-fat milk (230) 
Low-fat yogurt (230) 
Low-fat cheese (15) 
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Table 2. Baseline characteristic of study subjects 
a 
Variable DASH diet (n=20) Control diet (n=20) P 
b
 
Age (year) 13.85±2.64 14.8±2.74 0.30 
Weight (percentile) 76.02±25.66 73.98±16.04 0.03 
Height (percentile) 50.75±34.48 39.46±23.69 0.006 
Percentile BMI 85.45±14.17 80.76±15.29 0.88 
WC (cm) 83.25±15.1 79.2±9.11 0.07 
Serum Vitamin C (mg/dL) 0.42±0.21 0.36±0.21 <0.001 
BMI; body mass index, WC; waist circumference 
a 
Variables are expressed as mean ± SD.  
b 
p-values resulted from independent t tests for quantitative and Chi-square for qualitative 
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Table 3. Dietary intake of the study participants as a sum of the three one-day food records 
a 
Variable DASH diet (n=20) Control diet (n=20) P
b 
Energy (Kcal/day) 1144.58±154.65 1293.71±310.73 0.067 
Carbohydrate (g/day) 167.75±32.89 173.84±32.89 0.989 
Protein (g/day) 49.74±18.59 50.71±18.59 0.882 
Fat (g/day) 41.08±10.41 41.11±10.41 0.885 
Sodium (mg/day) 1172.35±398.36 1580.94±398.36 0.002 
Vitamin A (re/day) 613.74±383.34 501.35±383.34 0.386 
Vitamin E (mg/day) 14.69±6.74 12.46±6.74 0.287 
Vitamin C (mg/day) 72.55±38.66 54.43±38.66 0.140 
Vitamin K (ug/day) 35.08±17.96 26.89±17.96 0.219 
Vitamin B1 (mg/day) 0.9±0.22 0.83±0.22 0.355 
Vitamin B2 (mg/day) 1.38±0.35 1.23±0.35 0.261 
Vitamin D (ug/day) 1.91±1.38 0.75±1.38 0.021 
Potassium (mg/day) 1987.52±574.08 1642.36±574.08 0.040 
Calcium (mg/day) 754.26±246.96 545.28±246.96 0.017 
Selenium (mg/day) 0.08±0.08 0.07±0.08 0.683 
Zinc (mg/day) 6.11±1.78 5.52±1.78 0.261 
Iron (mg/day) 8.48±3.08 8.66±3.08 0.717 
Dietary Fiber (g/day) 14.43±4.42 12.10±4.42 0.139 
Soluble Fiber (g/day) 0.52±0.17 0.38±0.17 0.022 
a 
Variables are expressed as mean ± SD. 
b 
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83 64 7 5 9 
SGOT 
(U/L) 




































BMI, body mass index; WC, waist circumference; FFM, fat free mass; IL-6, interleukin 6; CRP, C-reactive protein,. SGOT, serum glutamic 
oxaloacetic transaminase; SGPT, serum glutamic pyruic transaminase; PTT, partial thromboplastin time 
a 
Variables are expressed as mean ± SD 
b
 It shows the comparison baseline and final values in each group obtained from Paired T test 
c
 It shows the comparison final values between DASH and control groups obtained from Independent t-test comparing endpoint 
measurements  
d 
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Table 5. The effects of dietary approach to stop hypertension (DASH) diet on complete blood count 
a 
 

















6.32±1.49 6.84±1.40 0.51±0.86 0.01 6.06±1.04 6.34±1.34 0.27±0.77 0.12 0.342 0.30 
RBC 
(mil/µl) 
5.25±0.5 5.58±0.44 0.32±0.36 0.001 5.2±0.52 5.29±0.5 0.08±0.44 0.40 0.010 0.02 
HGB 
(g/dl) 
14.49±1.53 14.94±1.01 0.45±0.80 0.02 14.21±1.80 14.16±1.57 
-
0.04±0.77 
0.8 0.054 0.005 
HCT (%) 42.24±4.10 43.56±3.27 1.32±2.36 0.02 42.16±4.34 41.93±3.89 
-
0.22±1.47 
0.49 0.130 0.006 
MCV (fl) 80.97±3.68 81.43±4.39 0.46±2.12 0.34 78.3±7.13 78.26±7.30 
-
0.03±4.39 
0.97 0.131 0.46 
MCH 
(pg) 






0.46 33.75±1.46 33.85±1.65 0.1±1.06 0.66 0.324 0.71 
WBC, white blood cells; HGB, haemoglobin; HCT, hematocrit; MCV, mean corpuscular volume; MCH, mean corpuscular haemoglobin; 
MCHC, mean corpuscular haemoglobin concentration. 
a 
Variables are expressed as mean ± SD 
b
 It shows the comparison baseline and final values in each group obtained from Paired T test 
c
 It shows the comparison final values between DASH and control groups obtained from Independent t-test comparing endpoint measurements  
d 
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